StonvexLoading…
StonvexStonvexStonvexCore line items from EVER's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $692.52M | $500.19M | $287.92M | $404.13M |
Operating Income | $58.34M | $31.75M | $-51.98M | $-24.79M |
Net Income | $99.31M | $32.17M | $-51.29M | $-24.42M |
EPS (Diluted) | $2.63 | $0.88 | $-1.54 | $-0.77 |
Total Assets | $326.91M | $210.53M | $110.92M | $156.52M |
Total Liabilities | $88.87M | $75.16M | $30.02M | $49.03M |
Cash & Equivalents | $171.38M | $102.12M | $37.96M | $30.84M |
Free Cash Flow OCF − CapEx | $90.32M | $62.45M | $-6.67M | $-20.08M |
Shares Outstanding | 37.75M | 36.65M | 33.35M | 31.61K |